APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stem Cell Exosome Therapeutic

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Stem Cell Exosome Therapeutic Industry Growth and Trends Forecast to 2032

12 August 2026113 pages

Choose your research edition.

Industry ResearchStem Cell Exosome Therapeutic Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cell Exosome Therapeutic Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Stem Cell Exosome Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cell Exosome Therapeutic Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cell Exosome Therapeutic Market Analysis and Forecast 2026-2032182 pages · $4,950 USD

Market perspective

According to APO Research, the global Stem Cell Exosome Therapeutic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Stem Cell Exosome Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Stem Cell Exosome Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Stem Cell Exosome Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Stem Cell Exosome Therapeutic market include CHA Biotech, ExoCoBio, Exopharm, OmniSpiant, BrainStorm Cell Therapeutics, Novadip Biosciences, Unicyte AG, Exogenus Therapeutics and Creative Medical Tech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Stem Cell Exosome Therapeutic market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Stem Cell Exosome Therapeutic market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Stem Cell Exosome Therapeutic market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Stem Cell Exosome Therapeutic.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Stem Cell Exosome Therapeutic market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Stem Cell Exosome Therapeutic Market by Company

CHA Biotech

ExoCoBio

Exopharm

OmniSpiant

BrainStorm Cell Therapeutics

Novadip Biosciences

Unicyte AG

Exogenus Therapeutics

Creative Medical Tech

Anjarium Biosciences

Capricor Therapeutics

Kimera Labs ReNeuron

Stem Cell Medicine

Codiak Biosciencesare

Aegle Therapeutics

Brexogen

Cell Care Therapeutics

Stem Cell Exosome Therapeutic Segment by Type

Mesenchymal Stem Cell (MSC)

Dendritic Cells

Umbilical MSC

Others

Stem Cell Exosome Therapeutic Segment by Application

Precision Medicine

Regenerative Medicine

Others

Stem Cell Exosome Therapeutic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Exosome Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Exosome Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Exosome Therapeutic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Stem Cell Exosome Therapeutic companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Stem Cell Exosome Therapeutic Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Stem Cell Exosome Therapeutic Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Stem Cell Exosome Therapeutic Market Share by Region (2021-2026) Table 4. Global Stem Cell Exosome Therapeutic Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Stem Cell Exosome Therapeutic Market Share by Region (2027-2032) Table 6. Global Stem Cell Exosome Therapeutic Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Stem Cell Exosome Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Stem Cell Exosome Therapeutic Market Size Share by Type (2021-2026) Table 9. Global Stem Cell Exosome Therapeutic Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Stem Cell Exosome Therapeutic Market Size Share Forecasted by Type (2027-2032) Table 11. North America Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Stem Cell Exosome Therapeutic Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Stem Cell Exosome Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Stem Cell Exosome Therapeutic Market Size Share by Application (2021-2026) Table 24. Global Stem Cell Exosome Therapeutic Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Stem Cell Exosome Therapeutic Market Size Share Forecasted by Application (2027-2032) Table 26. North America Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Stem Cell Exosome Therapeutic Industry Trends Table 37. Stem Cell Exosome Therapeutic Industry Drivers Table 38. Stem Cell Exosome Therapeutic Industry Opportunities and Challenges Table 39. Stem Cell Exosome Therapeutic Industry Restraints Table 40. Global Stem Cell Exosome Therapeutic Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Stem Cell Exosome Therapeutic Revenue Market Share by Company (2021-2026) Table 42. Global Stem Cell Exosome Therapeutic Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Stem Cell Exosome Therapeutic Key Company Headquarters & Area Served Table 44. Global Stem Cell Exosome Therapeutic Company, Product Type & Application Table 45. Global Stem Cell Exosome Therapeutic Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Stem Cell Exosome Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. CHA Biotech Company Information Table 49. CHA Biotech Business Overview Table 50. CHA Biotech Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. CHA Biotech Stem Cell Exosome Therapeutic Product Portfolio Table 52. CHA Biotech Recent Development Table 53. ExoCoBio Company Information Table 54. ExoCoBio Business Overview Table 55. ExoCoBio Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. ExoCoBio Stem Cell Exosome Therapeutic Product Portfolio Table 57. ExoCoBio Recent Development Table 58. Exopharm Company Information Table 59. Exopharm Business Overview Table 60. Exopharm Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Exopharm Stem Cell Exosome Therapeutic Product Portfolio Table 62. Exopharm Recent Development Table 63. OmniSpiant Company Information Table 64. OmniSpiant Business Overview Table 65. OmniSpiant Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. OmniSpiant Stem Cell Exosome Therapeutic Product Portfolio Table 67. OmniSpiant Recent Development Table 68. BrainStorm Cell Therapeutics Company Information Table 69. BrainStorm Cell Therapeutics Business Overview Table 70. BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Product Portfolio Table 72. BrainStorm Cell Therapeutics Recent Development Table 73. Novadip Biosciences Company Information Table 74. Novadip Biosciences Business Overview Table 75. Novadip Biosciences Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novadip Biosciences Stem Cell Exosome Therapeutic Product Portfolio Table 77. Novadip Biosciences Recent Development Table 78. Unicyte AG Company Information Table 79. Unicyte AG Business Overview Table 80. Unicyte AG Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Unicyte AG Stem Cell Exosome Therapeutic Product Portfolio Table 82. Unicyte AG Recent Development Table 83. Exogenus Therapeutics Company Information Table 84. Exogenus Therapeutics Business Overview Table 85. Exogenus Therapeutics Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Exogenus Therapeutics Stem Cell Exosome Therapeutic Product Portfolio Table 87. Exogenus Therapeutics Recent Development Table 88. Creative Medical Tech Company Information Table 89. Creative Medical Tech Business Overview Table 90. Creative Medical Tech Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Creative Medical Tech Stem Cell Exosome Therapeutic Product Portfolio Table 92. Creative Medical Tech Recent Development Table 93. Anjarium Biosciences Company Information Table 94. Anjarium Biosciences Business Overview Table 95. Anjarium Biosciences Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Anjarium Biosciences Stem Cell Exosome Therapeutic Product Portfolio Table 97. Anjarium Biosciences Recent Development Table 98. Capricor Therapeutics Company Information Table 99. Capricor Therapeutics Business Overview Table 100. Capricor Therapeutics Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Capricor Therapeutics Stem Cell Exosome Therapeutic Product Portfolio Table 102. Capricor Therapeutics Recent Development Table 103. Kimera Labs ReNeuron Company Information Table 104. Kimera Labs ReNeuron Business Overview Table 105. Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Product Portfolio Table 107. Kimera Labs ReNeuron Recent Development Table 108. Stem Cell Medicine Company Information Table 109. Stem Cell Medicine Business Overview Table 110. Stem Cell Medicine Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Stem Cell Medicine Stem Cell Exosome Therapeutic Product Portfolio Table 112. Stem Cell Medicine Recent Development Table 113. Codiak Biosciencesare Company Information Table 114. Codiak Biosciencesare Business Overview Table 115. Codiak Biosciencesare Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Codiak Biosciencesare Stem Cell Exosome Therapeutic Product Portfolio Table 117. Codiak Biosciencesare Recent Development Table 118. Aegle Therapeutics Company Information Table 119. Aegle Therapeutics Business Overview Table 120. Aegle Therapeutics Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Aegle Therapeutics Stem Cell Exosome Therapeutic Product Portfolio Table 122. Aegle Therapeutics Recent Development Table 123. Brexogen Company Information Table 124. Brexogen Business Overview Table 125. Brexogen Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Brexogen Stem Cell Exosome Therapeutic Product Portfolio Table 127. Brexogen Recent Development Table 128. Cell Care Therapeutics Company Information Table 129. Cell Care Therapeutics Business Overview Table 130. Cell Care Therapeutics Stem Cell Exosome Therapeutic Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Cell Care Therapeutics Stem Cell Exosome Therapeutic Product Portfolio Table 132. Cell Care Therapeutics Recent Development Table 133. North America Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Stem Cell Exosome Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Stem Cell Exosome Therapeutic Market Share by Country (2021-2026) Table 136. North America Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Stem Cell Exosome Therapeutic Market Share Forecast by Country (2027-2032) Table 138. Europe Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Stem Cell Exosome Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Stem Cell Exosome Therapeutic Market Share by Country (2021-2026) Table 141. Europe Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Stem Cell Exosome Therapeutic Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Stem Cell Exosome Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Stem Cell Exosome Therapeutic Market Share by Country (2021-2026) Table 146. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Stem Cell Exosome Therapeutic Market Share Forecast by Country (2027-2032) Table 148. Latin America Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Stem Cell Exosome Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Stem Cell Exosome Therapeutic Market Share by Country (2021-2026) Table 151. Latin America Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Stem Cell Exosome Therapeutic Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Stem Cell Exosome Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Stem Cell Exosome Therapeutic Market Share by Country (2021-2026) Table 156. Middle East & Africa Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Stem Cell Exosome Therapeutic Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Stem Cell Exosome Therapeutic Product Image Figure 3. Global Stem Cell Exosome Therapeutic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Stem Cell Exosome Therapeutic Market Size (2021-2032) & (US$ Million) Figure 5. Global Stem Cell Exosome Therapeutic Market Share by Region: 2025 VS 2032 Figure 6. Global Stem Cell Exosome Therapeutic Market Share by Region (2021-2032) Figure 7. North America Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Mesenchymal Stem Cell (MSC) Image Figure 13. Global Mesenchymal Stem Cell (MSC) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Dendritic Cells Image Figure 15. Global Dendritic Cells Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Umbilical MSC Image Figure 17. Global Umbilical MSC Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Stem Cell Exosome Therapeutic Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Stem Cell Exosome Therapeutic Market Share by Type 2025 VS 2032 Figure 22. North America Stem Cell Exosome Therapeutic Market Size Share by Type (2021-2032) Figure 23. Europe Stem Cell Exosome Therapeutic Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Share by Type (2021-2032) Figure 25. Latin America Stem Cell Exosome Therapeutic Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Stem Cell Exosome Therapeutic Market Size Share by Type (2021-2032) Figure 27. Precision Medicine Image Figure 28. Global Precision Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Regenerative Medicine Image Figure 30. Global Regenerative Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Stem Cell Exosome Therapeutic Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Stem Cell Exosome Therapeutic Market Share by Application 2025 VS 2032 Figure 35. North America Stem Cell Exosome Therapeutic Market Size Share by Application (2021-2032) Figure 36. Europe Stem Cell Exosome Therapeutic Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Stem Cell Exosome Therapeutic Market Size Share by Application (2021-2032) Figure 38. Latin America Stem Cell Exosome Therapeutic Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Stem Cell Exosome Therapeutic Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Stem Cell Exosome Therapeutic Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Stem Cell Exosome Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Stem Cell Exosome Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Stem Cell Exosome Therapeutic Market Share by Country (2021-2032) Figure 45. Europe Stem Cell Exosome Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Stem Cell Exosome Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Stem Cell Exosome Therapeutic Market Share by Country (2021-2032) Figure 48. Asia-Pacific Stem Cell Exosome Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Stem Cell Exosome Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Stem Cell Exosome Therapeutic Market Share by Country (2021-2032) Figure 51. Latin America Stem Cell Exosome Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Stem Cell Exosome Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Stem Cell Exosome Therapeutic Market Share by Country (2021-2032) Figure 54. Middle East & Africa Stem Cell Exosome Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Stem Cell Exosome Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Stem Cell Exosome Therapeutic Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Mesenchymal Stem Cell (MSC)
  • Dendritic Cells
  • Umbilical MSC
  • Others
Applications
  • Precision Medicine
  • Regenerative Medicine
  • Others
Companies covered
  • CHA Biotech
  • ExoCoBio
  • Exopharm
  • OmniSpiant
  • BrainStorm Cell Therapeutics
  • Novadip Biosciences
  • Unicyte AG
  • Exogenus Therapeutics
  • Creative Medical Tech
  • Anjarium Biosciences
  • Capricor Therapeutics
  • Kimera Labs ReNeuron
  • Stem Cell Medicine
  • Codiak Biosciencesare
  • Aegle Therapeutics
  • Brexogen
  • Cell Care Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Stem Cell Exosome Therapeutic Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Stem Cell Exosome Therapeutic Market Size by Region (2021-2032)
  5. 1.4.1 Global Stem Cell Exosome Therapeutic Market Size by Region (2021-2026)
  6. 1.4.2 Global Stem Cell Exosome Therapeutic Market Size by Region (2027-2032)
  7. 1.5 Key Regions Stem Cell Exosome Therapeutic Market Size (2021-2032)
  8. 1.5.1 North America Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Stem Cell Exosome Therapeutic Market Size Growth Rate (2021-2032)
2 Stem Cell Exosome Therapeutic Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Mesenchymal Stem Cell (MSC)
  3. 2.1.2 Dendritic Cells
  4. 2.1.3 Umbilical MSC
  5. 2.1.4 Others
  6. 2.2 Global Stem Cell Exosome Therapeutic Market Size by Type
  7. 2.2.1 Global Stem Cell Exosome Therapeutic Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Stem Cell Exosome Therapeutic Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Stem Cell Exosome Therapeutic Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Stem Cell Exosome Therapeutic Market Size by Regions
  11. 2.3.1 North America Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Stem Cell Exosome Therapeutic Market Size Breakdown by Type (2021-2026)
3 Stem Cell Exosome Therapeutic Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Precision Medicine
  3. 3.1.2 Regenerative Medicine
  4. 3.1.3 Others
  5. 3.2 Global Stem Cell Exosome Therapeutic Market Size by Application
  6. 3.2.1 Global Stem Cell Exosome Therapeutic Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Stem Cell Exosome Therapeutic Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Stem Cell Exosome Therapeutic Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Stem Cell Exosome Therapeutic Market Size by Regions
  10. 3.3.1 North America Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Stem Cell Exosome Therapeutic Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Stem Cell Exosome Therapeutic Industry Trends
  2. 4.2 Stem Cell Exosome Therapeutic Industry Drivers
  3. 4.3 Stem Cell Exosome Therapeutic Industry Opportunities and Challenges
  4. 4.4 Stem Cell Exosome Therapeutic Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Stem Cell Exosome Therapeutic Revenue (2021-2026)
  2. 5.2 Global Stem Cell Exosome Therapeutic Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Stem Cell Exosome Therapeutic Key Company Headquarters & Area Served
  4. 5.4 Global Stem Cell Exosome Therapeutic Company, Product Type & Application
  5. 5.5 Global Stem Cell Exosome Therapeutic Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Stem Cell Exosome Therapeutic Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Stem Cell Exosome Therapeutic Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Stem Cell Exosome Therapeutic Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 CHA Biotech
  2. 6.1.1 CHA Biotech Company Information
  3. 6.1.2 CHA Biotech Business Overview
  4. 6.1.3 CHA Biotech Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 CHA Biotech Stem Cell Exosome Therapeutic Product Portfolio
  6. 6.1.5 CHA Biotech Recent Developments
  7. 6.2 ExoCoBio
  8. 6.2.1 ExoCoBio Company Information
  9. 6.2.2 ExoCoBio Business Overview
  10. 6.2.3 ExoCoBio Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 ExoCoBio Stem Cell Exosome Therapeutic Product Portfolio
  12. 6.2.5 ExoCoBio Recent Developments
  13. 6.3 Exopharm
  14. 6.3.1 Exopharm Company Information
  15. 6.3.2 Exopharm Business Overview
  16. 6.3.3 Exopharm Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Exopharm Stem Cell Exosome Therapeutic Product Portfolio
  18. 6.3.5 Exopharm Recent Developments
  19. 6.4 OmniSpiant
  20. 6.4.1 OmniSpiant Company Information
  21. 6.4.2 OmniSpiant Business Overview
  22. 6.4.3 OmniSpiant Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 OmniSpiant Stem Cell Exosome Therapeutic Product Portfolio
  24. 6.4.5 OmniSpiant Recent Developments
  25. 6.5 BrainStorm Cell Therapeutics
  26. 6.5.1 BrainStorm Cell Therapeutics Company Information
  27. 6.5.2 BrainStorm Cell Therapeutics Business Overview
  28. 6.5.3 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
  30. 6.5.5 BrainStorm Cell Therapeutics Recent Developments
  31. 6.6 Novadip Biosciences
  32. 6.6.1 Novadip Biosciences Company Information
  33. 6.6.2 Novadip Biosciences Business Overview
  34. 6.6.3 Novadip Biosciences Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novadip Biosciences Stem Cell Exosome Therapeutic Product Portfolio
  36. 6.6.5 Novadip Biosciences Recent Developments
  37. 6.7 Unicyte AG
  38. 6.7.1 Unicyte AG Company Information
  39. 6.7.2 Unicyte AG Business Overview
  40. 6.7.3 Unicyte AG Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Unicyte AG Stem Cell Exosome Therapeutic Product Portfolio
  42. 6.7.5 Unicyte AG Recent Developments
  43. 6.8 Exogenus Therapeutics
  44. 6.8.1 Exogenus Therapeutics Company Information
  45. 6.8.2 Exogenus Therapeutics Business Overview
  46. 6.8.3 Exogenus Therapeutics Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Exogenus Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
  48. 6.8.5 Exogenus Therapeutics Recent Developments
  49. 6.9 Creative Medical Tech
  50. 6.9.1 Creative Medical Tech Company Information
  51. 6.9.2 Creative Medical Tech Business Overview
  52. 6.9.3 Creative Medical Tech Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Creative Medical Tech Stem Cell Exosome Therapeutic Product Portfolio
  54. 6.9.5 Creative Medical Tech Recent Developments
  55. 6.10 Anjarium Biosciences
  56. 6.10.1 Anjarium Biosciences Company Information
  57. 6.10.2 Anjarium Biosciences Business Overview
  58. 6.10.3 Anjarium Biosciences Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Anjarium Biosciences Stem Cell Exosome Therapeutic Product Portfolio
  60. 6.10.5 Anjarium Biosciences Recent Developments
  61. 6.11 Capricor Therapeutics
  62. 6.11.1 Capricor Therapeutics Company Information
  63. 6.11.2 Capricor Therapeutics Business Overview
  64. 6.11.3 Capricor Therapeutics Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Capricor Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
  66. 6.11.5 Capricor Therapeutics Recent Developments
  67. 6.12 Kimera Labs ReNeuron
  68. 6.12.1 Kimera Labs ReNeuron Company Information
  69. 6.12.2 Kimera Labs ReNeuron Business Overview
  70. 6.12.3 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Product Portfolio
  72. 6.12.5 Kimera Labs ReNeuron Recent Developments
  73. 6.13 Stem Cell Medicine
  74. 6.13.1 Stem Cell Medicine Company Information
  75. 6.13.2 Stem Cell Medicine Business Overview
  76. 6.13.3 Stem Cell Medicine Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Stem Cell Medicine Stem Cell Exosome Therapeutic Product Portfolio
  78. 6.13.5 Stem Cell Medicine Recent Developments
  79. 6.14 Codiak Biosciencesare
  80. 6.14.1 Codiak Biosciencesare Company Information
  81. 6.14.2 Codiak Biosciencesare Business Overview
  82. 6.14.3 Codiak Biosciencesare Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Codiak Biosciencesare Stem Cell Exosome Therapeutic Product Portfolio
  84. 6.14.5 Codiak Biosciencesare Recent Developments
  85. 6.15 Aegle Therapeutics
  86. 6.15.1 Aegle Therapeutics Company Information
  87. 6.15.2 Aegle Therapeutics Business Overview
  88. 6.15.3 Aegle Therapeutics Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Aegle Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
  90. 6.15.5 Aegle Therapeutics Recent Developments
  91. 6.16 Brexogen
  92. 6.16.1 Brexogen Company Information
  93. 6.16.2 Brexogen Business Overview
  94. 6.16.3 Brexogen Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Brexogen Stem Cell Exosome Therapeutic Product Portfolio
  96. 6.16.5 Brexogen Recent Developments
  97. 6.17 Cell Care Therapeutics
  98. 6.17.1 Cell Care Therapeutics Company Information
  99. 6.17.2 Cell Care Therapeutics Business Overview
  100. 6.17.3 Cell Care Therapeutics Stem Cell Exosome Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Cell Care Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
  102. 6.17.5 Cell Care Therapeutics Recent Developments
7 North America
  1. 7.1 North America Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
  3. 7.3 North America Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
  3. 8.3 Europe Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
  3. 10.3 South America Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Stem Cell Exosome Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Stem Cell Exosome Therapeutic Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst